David DeLucia | Head of Corporate FP&A / Investor Relations |
Enrique Conterno | Chief Executive Officer |
Thane Wettig | Interim Chief Executive Officer |
Juan Graham | Chief Financial Officer |
Chris Chung | Senior Vice President of China Operations |
Mark Eisner | Chief Medical Officer |
John Hunter | Chief Scientific Officer |
Jason Gerberry | Bank of America |
Annabel Samimy | Stifel |
Alexandra Ramsey | William Blair |
Paul Choi | Goldman Sachs |
Good day, and thank you for standing by. Welcome to the FibroGen's Second Quarter 2023 Earnings Call. At this time, all participants are in listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.